Analysis of clinical characteristics and prognostic factors in patients with non-Hodgkin lymphoma and HBV infection.
10.3760/cma.j.issn.0253-2727.2018.07.007
- VernacularTitle:非霍奇金淋巴瘤合并HBV感染患者的临床特征及预后相关因素分析
- Author:
Ling ZHANG
1
;
Xiao Li YUAN
;
Li JIANG
;
Jing YANG
;
Jian Min GUO
;
Jie SHI
;
Ping Chong LEI
;
Yin ZHANG
;
Zun Min ZHU
Author Information
1. Institute of Hematology of Henan People's Hospital, Zhengzhou 450003, China.
- Publication Type:Journal Article
- Keywords:
Hepatitis B virus;
Lymphoma, non-Hodgkin’s
- MeSH:
Hepatitis B;
Hepatitis B Antibodies;
Hepatitis B Surface Antigens;
Humans;
Lymphoma, Non-Hodgkin;
Prognosis
- From:
Chinese Journal of Hematology
2018;39(7):563-568
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To explore the clinical characteristics and prognostic factors of the patients with non-Hodgkin's Lymphoma (NHL) complicated with HBV infection, so as to provide a basis for clinical accurate diagnosis and prognosis evaluation. Methods: The data of 313 newly diagnosed NHL patients from August 2012 to July 2016 were collected. The HBV serological markers were detected by ELISA, and HBV DNA was quantified by full automatic microparticle chemiluminescence immunoassay (≥1×10(5) copies/ml as high copy group, 1×10(3)-<1×10(5) copies/ml as low copy group). The relationship between HBV infection and prognosis was analyzed combined with the clinical features of the patients, and the HBV detection rate was compared with that of the common population (from the national HBV sero epidemiological data). Results: ①The positive rate of HBsAg in NHL patients was 12.5% (39/313), which was higher than 7.2% in the general population (χ(2)=14.596, P<0.001). HBV infection in the past (HBsAg negative but HBcAb positive) in 114 cases (36.4%), the incidence was slightly higher than that in the general population (34.1%). ②Compared HBsAg positive group with the negative group, the proportion of B cell type (87.2% vs 70.3%, P=0.027), Ann Arbor stage Ⅲ-Ⅳ(69.2% vs 34.6%, P<0.001), IPI score 3-5 (74.4% vs 50%, P=0.004), LDH level (79.5% vs 47.8%, P<0.001) and liver involvement (45.5% vs 31.7%, P=0.006) were all higher. The difference was statistically significant. ③Compared the HBV infected group (114 cases) with the non-infected group (160 cases), the difference had statistical significance in the proportion of Ann Arbor stage Ⅲ-Ⅳ (P=0.023) and IPI score 3-5 scores P=0.035). ④Compared HBV DNA positive group (30 cases) with negative group (71 cases), Ann Arbor stage Ⅲ-Ⅳ (P=0.011), IPI score 3-5 score (P=0.030), LDH level (P=0.025) and liver involvement (P<0.001) in the proportion of patients had statistical significance. The positive patients were divided into HBV DNA high and low copy groups with 1×10(5) copies of /ml as the boundary. The results showed that there was no statistical difference between the two groups (P>0.05). Conclusions: The HBV infection rate of NHL patients is significantly higher than that of the general population, and HBV infection is more closely related to B cell type NHL. Patients with HBV infection and HBV DNA positive had late Ann Arbor stage, high IPI score, high LDH level and liver involvement, and the prognosis is poor.
